They found that the tumor growth rate was inhibited, and the mRNA and protein expression levels of oncogenes p53 and Rb were significantly upregulated, suggesting that SPP could hinder the growth of S180 sarcoma in vivo (Liu and Meng, 2008). The gene discussed is HM13; the disease is neoplasm.